Veschi V, Turdo A, Modica C, Verona F, Di Franco S, Gaggianesi M
Nat Commun. 2023; 14(1):1351.
PMID: 36906579
PMC: 10008571.
DOI: 10.1038/s41467-023-36922-1.
Lu M, Liu H, Zheng B, Sun S, Chen C
Cancers (Basel). 2022; 14(20).
PMID: 36291901
PMC: 9600751.
DOI: 10.3390/cancers14205117.
Zheng R, Chen G, Li X, Wei X, Liu C, Derwahl M
Int J Clin Exp Pathol. 2020; 12(11):3992-4001.
PMID: 31933795
PMC: 6949779.
Gao Y, Wang F, Zhang L, Kang M, Zhu L, Xu L
Cancer Med. 2020; 9(4):1515-1528.
PMID: 31894666
PMC: 7013059.
DOI: 10.1002/cam4.2815.
Kim H, Koo J
Front Endocrinol (Lausanne). 2019; 10:523.
PMID: 31428052
PMC: 6688385.
DOI: 10.3389/fendo.2019.00523.
Prognostic Value of CD133 and SOX2 in Advanced Cancer.
Han S, Huang T, Wu X, Wang X, Liu S, Yang W
J Oncol. 2019; 2019:3905817.
PMID: 30693028
PMC: 6332999.
DOI: 10.1155/2019/3905817.
Single-Cell Analysis of [18F]Fluorodeoxyglucose Uptake by Droplet Radiofluidics.
Turkcan S, Nguyen J, Vilalta M, Shen B, Chin F, Pratx G
Anal Chem. 2015; 87(13):6667-73.
PMID: 26035453
PMC: 4669076.
DOI: 10.1021/acs.analchem.5b00792.
The Beneficial Effects of Valproic Acid in Thyroid Cancer Are Mediated through Promoting Redifferentiation and Reducing Stemness Level: An In Vitro Study.
Haghpanah V, Malehmir M, Larijani B, Ahmadian S, Alimoghaddam K, Heshmat R
J Thyroid Res. 2014; 2014:218763.
PMID: 24963441
PMC: 4052487.
DOI: 10.1155/2014/218763.
Mechanisms of therapeutic resistance in cancer (stem) cells with emphasis on thyroid cancer cells.
Hombach-Klonisch S, Natarajan S, Thanasupawat T, Medapati M, Pathak A, Ghavami S
Front Endocrinol (Lausanne). 2014; 5:37.
PMID: 24723911
PMC: 3971176.
DOI: 10.3389/fendo.2014.00037.
Loss of CPSF2 expression is associated with increased thyroid cancer cellular invasion and cancer stem cell population, and more aggressive disease.
Nilubol N, Boufraqech M, Zhang L, Kebebew E
J Clin Endocrinol Metab. 2014; 99(7):E1173-82.
PMID: 24654752
PMC: 4079301.
DOI: 10.1210/jc.2013-4140.
Recent insights into the cell biology of thyroid angiofollicular units.
Colin I, Denef J, Lengele B, Many M, Gerard A
Endocr Rev. 2013; 34(2):209-38.
PMID: 23349248
PMC: 3610675.
DOI: 10.1210/er.2012-1015.
Role of the wnt pathway in thyroid cancer.
Sastre-Perona A, Santisteban P
Front Endocrinol (Lausanne). 2012; 3:31.
PMID: 22645520
PMC: 3355838.
DOI: 10.3389/fendo.2012.00031.
HIF-1α and HSP90: target molecules selected from a tumorigenic papillary thyroid carcinoma cell line.
Mo J, Choi I, Jeong W, Jeon E, Ahn S
Cancer Sci. 2011; 103(3):464-71.
PMID: 22151618
PMC: 7713618.
DOI: 10.1111/j.1349-7006.2011.02181.x.
Thyroid cancer stem cells.
Lin R
Nat Rev Endocrinol. 2011; 7(10):609-16.
PMID: 21788969
DOI: 10.1038/nrendo.2011.127.
